Cite

HARVARD Citation

    Sharma, A. et al. (n.d.). MDNA132 is an IL-13 Superkine selective to IL-13Rα2 with broad potential for delivery of immunotherapies to the tumor microenvironment. European journal of cancer. pp. S127-S128. [Online]. 
  
Back to record